Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
Part of paid clinical trials in Memphis, Tennessee.
- Sponsor
- St. Jude Children's Research Hospital
- Study ID
- NCT06421987
- Status
- Recruiting
Conditions
- Hodgkin Lymphoma, Adult
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Near Infrared Spectroscopy (NIRS) — DEVICENIRS is a portable, non-invasive, brain imaging device.
Study Details
SURVIVORS Study participants are being asked to take part in this research study called HODNIRS because the participant is a survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. The study is being done to help investigators understand the link between long term effects of chest radiation and bleomycin for HL and brain function in survivors. Primary Objective To evaluate dynamic changes in CBF and oxygenation during exercise with Near Infrared Spectroscopy (NIRS) in HL survivors and non-cancer controls matched for age, sex, race, and ethnicity. . Secondary Objectives To examine the degree of CO2 clearance (DLCO/ETCO2) during rest and exercise in Hodgkin Lymphoma (HL) survivors compared to non-cancer controls matched for age, sex, race, and ethnicity. CONTROLS Volunteers are being asked to take part in this research study because they are non-first degree relative or friend of someone who received treatment for a childhood cancer or similar illness at St. Jude Children's Research Hospital or are an employee/affiliate of St. Jude Children's Research Hospital and have agreed to be a St. Jude Life Cohort Study (SJLIFE) community control.
Key Dates
- Start date
- May 6, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: SURVIVORA survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. and Control: Voluntarily taking part in this study because you are a relative, friend or employee of St. Jude Children's Research Hospital.
Primary Outcome Measure
Near-Infrared Spectroscopy (NIRS) [ Time Frame: Baseline ]
Central Contacts
- Nicholas Phillips, PhD888-226-4343
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | Nicholas Phillips, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Memphis, TN
Related Studies
- Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaPHASE1 · Recruiting · Marker Therapeutics, Inc. · Duarte, California
- ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin LymphomaPHASE2 · Not Yet Recruiting · Michael Spinner, MD · Davis, California